154 related articles for article (PubMed ID: 25736383)
1. Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use Nationally.
Shumway DA; Griffith KA; Pierce LJ; Feng M; Moran JM; Stenmark MH; Jagsi R; Hayman JA
J Oncol Pract; 2015 May; 11(3):e373-9. PubMed ID: 25736383
[TBL] [Abstract][Full Text] [Related]
2. Provider variability in intensity modulated radiation therapy utilization among Medicare beneficiaries in the United States.
Grant SR; Smith BD; Likhacheva AO; Shirvani SM; Rosen DB; Guadagnolo BA; Shumway DA; Holliday EB; Chamberlain D; Walker GV
Pract Radiat Oncol; 2018; 8(5):e329-e336. PubMed ID: 29861349
[TBL] [Abstract][Full Text] [Related]
3. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011.
Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334
[TBL] [Abstract][Full Text] [Related]
4. IMRT (intensity modulated radiation therapy): progress in technology and reimbursement.
Young R; Snyder B
Radiol Manage; 2001; 23(6):20-6, 28, 30 passim; quiz 33-5. PubMed ID: 11793560
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort.
Guadagnolo BA; Liu CC; Cormier JN; Du XL
Cancer; 2010 Jul; 116(14):3505-12. PubMed ID: 20564123
[TBL] [Abstract][Full Text] [Related]
6. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
[TBL] [Abstract][Full Text] [Related]
7. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
9. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
10. [Intensity Modulated Radiation Therapy (IMRT)].
Maebayashi K; Nasu S; Seki K; Kiyoduka M; Hashimoto Y; Mitsuhashi N
Gan To Kagaku Ryoho; 2006 Apr; 33(4):436-43. PubMed ID: 16612150
[TBL] [Abstract][Full Text] [Related]
11. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT).
Hartford AC; Galvin JM; Beyer DC; Eichler TJ; Ibbott GS; Kavanagh B; Schultz CJ; Rosenthal SA; ;
Am J Clin Oncol; 2012 Dec; 35(6):612-7. PubMed ID: 23165357
[TBL] [Abstract][Full Text] [Related]
12. Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans Affairs.
Ahuja V; Sohn MW; Birge JR; Syverson C; Budiman-Mak E; Emanuele N; Cooper JM; Huang ES
J Manag Care Spec Pharm; 2015 Dec; 21(12):1214-34. PubMed ID: 26679970
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
Lievens Y; De Schutter H; Stellamans K; Rosskamp M; Van Eycken L;
Eur J Cancer; 2017 Oct; 84():102-113. PubMed ID: 28802187
[TBL] [Abstract][Full Text] [Related]
14. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
[TBL] [Abstract][Full Text] [Related]
15. Variation in critical care unit admission rates and outcomes for patients with acute coronary syndromes or heart failure among high- and low-volume cardiac hospitals.
van Diepen S; Bakal JA; Lin M; Kaul P; McAlister FA; Ezekowitz JA
J Am Heart Assoc; 2015 Feb; 4(3):e001708. PubMed ID: 25725089
[TBL] [Abstract][Full Text] [Related]
16. Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
Khanna A; Hu JC; Gu X; Nguyen PL; Lipsitz S; Palapattu GS
J Urol; 2013 Jan; 189(1):75-9. PubMed ID: 23164382
[TBL] [Abstract][Full Text] [Related]
17. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance analysis of a large multicenter practice: does increased complexity of intensity-modulated radiotherapy lead to increased error frequency?
Olson AC; Wegner RE; Scicutella C; Heron DE; Greenberger JS; Huq MS; Bednarz G; Flickinger JC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e77-82. PubMed ID: 21497453
[TBL] [Abstract][Full Text] [Related]
19. Technological evolution of radiation treatment: Implications for clinical applications.
Pacelli R; Caroprese M; Palma G; Oliviero C; Clemente S; Cella L; Conson M
Semin Oncol; 2019 Jun; 46(3):193-201. PubMed ID: 31395286
[TBL] [Abstract][Full Text] [Related]
20. Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).
McGarry CK; Butterworth KT; Trainor C; O'Sullivan JM; Prise KM; Hounsell AR
Phys Med Biol; 2011 Apr; 56(8):2445-57. PubMed ID: 21427488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
